Last viewed: LLY

Prices are updated after-hours

LLY Nyse 2020 - 12 - 16

Eli Lilly and Company

LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

(0.0% 1d) (-1.6% 1m) (101.6% 1y) (0.0% 2d) (0.0% 3d) (-0.1% 7d) (-5.47% volume)
Earnings Calendar: 2024-02-06
Market Cap: $ 713,354,965,628
http://www.lilly.com
Sec Filling | Patents | 33625 employees

(US) Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Drugs

Alimta (Pemetrexed disodium)
Amyvid (Florbetapir F 18)
Bamlanivimab (Bamlanivimab)
Baqsimi (glucagon)
BASAGLAR KwikPen (Insulin glargine)
BASAGLAR Tempo Pen (Insulin glargine)
Cialis (Tadalafil)
Cymbalta (Duloxetine hydrochloride)
CYRAMZA (ramucirumab)
Effient (Prasugrel hydrochloride)
EMGALITY (galcanezumab-gnlm)
Etesevimab (Etesevimab)
Evista (Raloxifene hydrochloride)
Forteo (Teriparatide)
Gemzar (Gemcitabine hydrochloride)
Glucagon (glucagon)
Humalog (Insulin lispro)
Humalog Junior KwikPen (Insulin lispro)
Humalog KwikPen (Insulin lispro)
Humalog Mix50/50 (Insulin lispro)
Humalog Mix50/50 KwikPen (Insulin lispro)
Humalog Mix75/25 (Insulin lispro)
Humalog Mix75/25 KwikPen (Insulin lispro)
Humalog Tempo Pen (Insulin lispro)
HUMATROPE (Somatropin)
Humulin 70/30 (Insulin human)
Humulin 70/30 KwikPen (Insulin human)
Humulin N (Insulin human)
Humulin R (Insulin human)
Humulin R U-500 (Insulin human)
Humulin R U-500 KwikPen (Insulin human)
Insulin Lispro (Insulin lispro)
Insulin Lispro Junior KwikPen (Insulin lispro)
Insulin Lispro KwikPen (Insulin lispro)
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (Insulin lispro)
LARTRUVO (olaratumab)
LYUMJEV (Insulin lispro-aabc)
LYUMJEV Junior KwikPen (Insulin lispro-aabc)
LYUMJEV KwikPen (Insulin lispro-aabc)
LYUMJEV Tempo Pen (Insulin lispro-aabc)
Olumiant (baricitinib)
Portrazza (necitumumab)
RETEVMO (selpercatinib)
Reyvow (lasmiditan)
Sterile Diluent (diluent)
Strattera (Atomoxetine hydrochloride)
Symbyax (Olanzapine and Fluoxetine hydrochloride)
TALTZ (ixekizumab)
TAUVID (Flortaucipir F-18)
Trulicity (Dulaglutide)
Verzenio (abemaciclib)
Zyprexa (Olanzapine)
ZYPREXA Intramuscular (Olanzapine)
ZYPREXA Relprevv (Olanzapine pamoate)
ZYPREXA Zydis (Olanzapine)

add to watch list Paper trade email alert is off

Press-releases

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
AUTL | $4.9 -2.39% -2.45% 790K

|

Health Technology

| Email alert Add to watchlist
BDTX A | $5.22 -0.38% -0.38% 370K

|

Health Technology

| Email alert Add to watchlist
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| Email alert Add to watchlist
CRGX | $19.89 -4.56% -4.38% 140K

|

| Email alert Add to watchlist
therapeutics

Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | $9.48 -8.41% 43.47% 22

|

Health Technology

| -8.41% | O: -100.0% H: NaN% C: Infinity%
ALPMY | $9.2715 -2.92% -1.11% 500K

|

| -9.9% | O: -8.65% H: 3.19% C: 1.6%
JNJ | $147.59 0.05% -0.18% 6.4M

|

Health Technology

| -2.06% | O: -1.65% H: 0.0% C: 0.0%
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -1.16% | O: -0.0% H: 0.52% C: -1.04%
growth market

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -0.14% | O: 1.06% H: 0.47% C: -0.03%
fda device disease test granted blood designation for alzheimer's roche

Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -0.85% | O: -0.71% H: 0.0% C: 0.0%
drug preclinical meeting

Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published: 2024-04-09 (Crawled : 22:00) - prnewswire.com
SNYNF | $92.966 0.07% -2.18% 630

|

Health Technology

| -1.37% | O: -0.01% H: 0.0% C: 0.0%
TMO | $557.87 -1.3% -0.24% 860K

|

Health Technology

| -5.32% | O: -2.01% H: 0.0% C: 0.0%
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -0.85% | O: -0.71% H: 0.0% C: 0.0%
BIO | $300.41 -0.01% 0.0% 170K

|

Health Technology

| -11.51% | O: -2.71% H: 0.52% C: 0.24%
AVTR | $24.71 -1.0% 0.0% 2.4M

|

Process Industries

| -4.45% | O: -1.7% H: 1.08% C: 0.55%
THMO | $0.8426 2.76% 4.54% 12K

|

Health Technology

| 1.36% | O: 4.99% H: 2.78% C: -2.1%
SNY | $46.24 0.68% 0.63% 1.6M

|

Health Technology

| -1.39% | O: -0.32% H: 0.0% C: 0.0%
global growth market

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -0.85% | O: -0.71% H: 0.0% C: 0.0%
ORIC | $9.54 -2.65% -2.83% 330K

|

Health Technology

| -10.59% | O: -2.81% H: 1.54% C: -3.57%
NRIX | $15.46 -7.65% -8.28% 2M

|

Health Technology

| 9.76% | O: 18.35% H: 1.98% C: -5.88%
therapeutics

Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published: 2024-04-08 (Crawled : 22:00) - prnewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M

|

Health Technology

| -2.77% | O: -0.3% H: 0.0% C: 0.0%
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -3.41% | O: 0.05% H: 0.02% C: -2.62%
MOR | $18.02 -0.22% -0.22% 630K

|

Health Technology

| -0.72% | O: 0.06% H: 0.22% C: 0.0%
KNSA 4 | $17.44 0.87% 0.63% 310K

|

Health Technology

| -1.36% | O: 0.23% H: 1.58% C: 0.06%
IMAB | $1.8 -0.55% 0.0% 400K

|

Health Technology

| -0.55% | O: -0.55% H: 1.39% C: 0.0%
GLPG | $29.8 -1.49% -1.36% 150K

|

Health Technology

| -6.47% | O: 0.0% H: 0.39% C: -0.66%
positive growth market

AMERICAN SKIN ASSOCIATION SPRING GALA CELEBRATES OUTSTANDING HONOREES
Published: 2024-04-05 (Crawled : 23:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| Email alert Add to watchlist
association spring skin

IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
Published: 2024-04-05 (Crawled : 12:30) - globenewswire.com
IOBT | $1.51 -2.58% -2.65% 130K

|

| -11.7% | O: -0.58% H: 0.0% C: -5.88%
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -3.94% | O: -2.06% H: 2.77% C: 2.45%
biotech business

The Top 11 Companies Hiring in Biopharma Now
Published: 2024-04-04 (Crawled : 05:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M

|

Health Technology

| -2.46% | O: 1.53% H: 0.0% C: 0.0%
companies biopharma

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000059478-24-000082	4	2024-03-11	2024-02-12	Buy	A	186	186
0000059478-24-000082	4	2024-03-11	2024-02-12	Buy	A	184	184
0000059478-24-000082	4	2024-03-11	2024-03-11	Sell	S	750	7880
0000059478-24-000075	4	2024-02-21	2024-02-20	Buy	A	13	2098

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

45%

55%

Top 10 Gainers

KAVL | $6.3 135.96% 57.45% 44M

|

Wholesale Trade

PXMD | $0.74 79.7% 44.16% 4.5M

|

Health Technology

DYNT | $0.3704 -5.27% 43.09% 5.5M

|

Health Technology

LGVN P | $2.93 73.37% 42.52% 56M

|

HUBC | $1.95 50.0% 32.99% 73M

|

SPCB | $0.4004 45.07% 31.75% 130M

|

Electronic Technology

ONVO | $1.35 33.65% 24.62% 53M

|

Health Technology

OMQS | $0.7038 35.35% 24.3% 3.5M

|

Professional, Scientific, and T...

SNPO | $10.54 29.48% 22.88% 3.9M

|

EEIQ | $1.16 27.46% 20.86% 6.9K

|

Educational Services

Last 48 Hours Insiders Buying

RMCF | $3.6492 2.51% -7.2% 7.1K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar